Avalo Therapeutics (AVTX) Other Gross PP&E Adjustments (2016 - 2025)
Avalo Therapeutics (AVTX) has disclosed Other Gross PP&E Adjustments for 12 consecutive years, with -$402000.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 64.71% year-over-year to -$402000.0, compared with a TTM value of -$402000.0 through Sep 2025, up 64.71%, and an annual FY2024 reading of $620000.0, down 13.65% over the prior year.
- Other Gross PP&E Adjustments was -$402000.0 for Q3 2025 at Avalo Therapeutics, up from -$487000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $718000.0 in Q4 2023 and bottomed at -$1.9 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$795052.6, with a median of -$846000.0 recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments crashed 159.74% in 2022, then soared 64.71% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $587000.0 in 2021, then decreased by 0.85% to $582000.0 in 2022, then increased by 23.37% to $718000.0 in 2023, then decreased by 13.65% to $620000.0 in 2024, then crashed by 164.84% to -$402000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for AVTX at -$402000.0 in Q3 2025, -$487000.0 in Q2 2025, and -$615000.0 in Q1 2025.